ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

PLSE Pulse Biosciences Inc

7.34
0.65 (9.72%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Pulse Biosciences Inc PLSE NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.65 9.72% 7.34 18:27:30
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
6.71 6.65 7.21 7.19 6.69
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
24/4/202415:05BWPulse Biosciences Schedules First Quarter 2024 Financial..
28/3/202415:12BWPulse Biosciences Reports Business Updates and Fourth..
28/3/202415:10BWPulse Biosciences Announces Plans to Initiate a Rights..
14/3/202415:05BWPulse Biosciences Schedules Fourth Quarter & Full Year 2023..
11/3/202408:10EDGAR2Form 8-K - Current report
08/3/202412:17BWPulse Biosciences Announces FDA 510(k) Clearance for its..
14/2/202408:22EDGAR2Form 8-K - Current report
14/2/202407:00BWPulse Biosciences Announces Positive 60-Day Follow-Up..
31/1/202407:00BWPulse Biosciences Announces Preliminary Findings from its..
09/1/202408:20EDGAR2Form 8-K - Current report
02/1/202408:20EDGAR2Form 8-K - Current report
02/1/202407:00BWPulse Biosciences Files 510(k) Submission with U.S. FDA for..
22/12/202308:08EDGAR2Form 8-K - Current report
20/12/202308:06EDGAR2Form 8-K - Current report
20/12/202307:00BWPulse Biosciences Announces First-in-Human Procedures with..
27/11/202316:29EDGAR2Form DEF 14A - Other definitive proxy statements
27/11/202308:08EDGAR2Form 8-K - Current report
21/11/202308:03EDGAR2Form 8-K - Current report
21/11/202307:00BWPulse Biosciences Files 510(k) Submission with U.S. FDA for..
17/11/202308:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202308:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202315:05BWPulse Biosciences to Present at the 35th Annual Piper..
13/11/202316:21EDGAR2Form PRE 14A - Other preliminary proxy statements
13/11/202316:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202308:12EDGAR2Form 8-K - Current report
13/11/202307:00BWPulse Biosciences Reports Business Updates and Third Quarter..
10/11/202315:56BWUPDATE Pulse Biosciences Announces New Time for Third..
03/11/202316:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202316:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202315:05BWPulse Biosciences Schedules Third Quarter 2023 Financial..
24/10/202307:00BWPulse Biosciences Appoints Dr. Niv Ad as Chief Science..
02/10/202307:00BWPulse Biosciences Announces Collaboration with CardioNXT for..
29/9/202307:00BWPulse Biosciences’ Nanosecond Pulsed Field Ablation (nsPFA™)..
27/9/202307:00BWPulse Biosciences’ First Study in a Surgical Application of..
12/9/202308:15EDGAR2Form 8-K - Current report
07/9/202315:05BWPulse Biosciences to Present at Gilmartin Group Emerging..
30/8/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
24/8/202315:05BWPulse Biosciences Clarifies Details of Recent S-3 Filing
11/8/202315:49EDGAR2Form S-3 - Registration statement under Securities Act of..
10/8/202315:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202315:14EDGAR2Form 8-K - Current report
10/8/202315:05BWPulse Biosciences Reports Business Updates and Second..
27/7/202315:05BWPulse Biosciences Schedules Second Quarter 2023 Financial..
20/7/202308:25EDGAR2Form 8-K - Current report
14/7/202319:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/7/202319:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/5/202306:00BWPulse Biosciences’ Nanosecond Pulsed Field Ablation (nsPFA™)..
11/5/202315:05BWPulse Biosciences Reports Business Updates and First Quarter..
10/5/202308:29BWPulse Biosciences, Inc. Announces Planned Redemption of..
03/5/202307:00BWPulse Biosciences, Inc. Appoints Dr. Gan Dunnington as Chief..

Su Consulta Reciente

Delayed Upgrade Clock